Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation-difference between branded and generic drugs

Ritsuko Matsuo, Syouko Tanaka, Michiko Kanou, Kimiko Isono, Yasuha Tanaka, Tomoko Taura, Yuki Asada, Yukiko Akamine, Hashimu Sawai, Masakazu Kinosita, Tomomi Sudou, Yoshiko Kunoki, Akiko Miki, Satoko Hori, Hiroki Satoh, Hisakazu Ohtani, Yasufumi Sawada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this study was to assess the bitterness intensity and pH of the solutions of clarithromycin dry syrup (CAM-DS), carbocisteine preparation (CC), and the concomitant use of both drugs. We conducted 6 types of human gustatory sensation tests with 6 healthy male volunteers. As a result, there was almost no difference in the bitterness intensity of CAM-DS between the branded (the latest and former preparations) and the generic formulations. The bitterness intensity of CAM-DS (the latest and former preparations of the branded as well as the generic formulations) was almost equally enhanced by mixing it with either the branded CC-DS or the branded and the generic carbocisteine granule (CC-Gr). On this occasion, the enhancing the bitterness of the branded CAM-DS (latest and former preparation) was nearly avoided safely by dosage form's changing CC-DS or CC-Gr to the branded CC-Sy. However, unlike the branded CC-Sy, some generic CC-Sy failed to suppress the bitterness. Furthermore, it was proven that some generic CAM-DS were shown to exhibit bitterness when mixed with even branded CC-Sy. In conclusion, it should be noted that the extent of bitterness of the mixture of CAM-DS and CC highly varies among the generic formulations.

Original languageEnglish
Pages (from-to)479-485
Number of pages7
JournalYakugaku Zasshi
Volume128
Issue number3
DOIs
Publication statusPublished - 2008 Mar
Externally publishedYes

Fingerprint

Generic Drugs
Clarithromycin
Dosage Forms
Healthy Volunteers
Pharmaceutical Preparations

Keywords

  • Bitterness
  • Branded formulation
  • Carbocisteine
  • Clarithromycin
  • Generic formulation

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation-difference between branded and generic drugs. / Matsuo, Ritsuko; Tanaka, Syouko; Kanou, Michiko; Isono, Kimiko; Tanaka, Yasuha; Taura, Tomoko; Asada, Yuki; Akamine, Yukiko; Sawai, Hashimu; Kinosita, Masakazu; Sudou, Tomomi; Kunoki, Yoshiko; Miki, Akiko; Hori, Satoko; Satoh, Hiroki; Ohtani, Hisakazu; Sawada, Yasufumi.

In: Yakugaku Zasshi, Vol. 128, No. 3, 03.2008, p. 479-485.

Research output: Contribution to journalArticle

Matsuo, R, Tanaka, S, Kanou, M, Isono, K, Tanaka, Y, Taura, T, Asada, Y, Akamine, Y, Sawai, H, Kinosita, M, Sudou, T, Kunoki, Y, Miki, A, Hori, S, Satoh, H, Ohtani, H & Sawada, Y 2008, 'Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation-difference between branded and generic drugs', Yakugaku Zasshi, vol. 128, no. 3, pp. 479-485. https://doi.org/10.1248/yakushi.128.479
Matsuo, Ritsuko ; Tanaka, Syouko ; Kanou, Michiko ; Isono, Kimiko ; Tanaka, Yasuha ; Taura, Tomoko ; Asada, Yuki ; Akamine, Yukiko ; Sawai, Hashimu ; Kinosita, Masakazu ; Sudou, Tomomi ; Kunoki, Yoshiko ; Miki, Akiko ; Hori, Satoko ; Satoh, Hiroki ; Ohtani, Hisakazu ; Sawada, Yasufumi. / Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation-difference between branded and generic drugs. In: Yakugaku Zasshi. 2008 ; Vol. 128, No. 3. pp. 479-485.
@article{76a6adb0fc1941fba2f8c84f113ab694,
title = "Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation-difference between branded and generic drugs",
abstract = "The purpose of this study was to assess the bitterness intensity and pH of the solutions of clarithromycin dry syrup (CAM-DS), carbocisteine preparation (CC), and the concomitant use of both drugs. We conducted 6 types of human gustatory sensation tests with 6 healthy male volunteers. As a result, there was almost no difference in the bitterness intensity of CAM-DS between the branded (the latest and former preparations) and the generic formulations. The bitterness intensity of CAM-DS (the latest and former preparations of the branded as well as the generic formulations) was almost equally enhanced by mixing it with either the branded CC-DS or the branded and the generic carbocisteine granule (CC-Gr). On this occasion, the enhancing the bitterness of the branded CAM-DS (latest and former preparation) was nearly avoided safely by dosage form's changing CC-DS or CC-Gr to the branded CC-Sy. However, unlike the branded CC-Sy, some generic CC-Sy failed to suppress the bitterness. Furthermore, it was proven that some generic CAM-DS were shown to exhibit bitterness when mixed with even branded CC-Sy. In conclusion, it should be noted that the extent of bitterness of the mixture of CAM-DS and CC highly varies among the generic formulations.",
keywords = "Bitterness, Branded formulation, Carbocisteine, Clarithromycin, Generic formulation",
author = "Ritsuko Matsuo and Syouko Tanaka and Michiko Kanou and Kimiko Isono and Yasuha Tanaka and Tomoko Taura and Yuki Asada and Yukiko Akamine and Hashimu Sawai and Masakazu Kinosita and Tomomi Sudou and Yoshiko Kunoki and Akiko Miki and Satoko Hori and Hiroki Satoh and Hisakazu Ohtani and Yasufumi Sawada",
year = "2008",
month = "3",
doi = "10.1248/yakushi.128.479",
language = "English",
volume = "128",
pages = "479--485",
journal = "Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation-difference between branded and generic drugs

AU - Matsuo, Ritsuko

AU - Tanaka, Syouko

AU - Kanou, Michiko

AU - Isono, Kimiko

AU - Tanaka, Yasuha

AU - Taura, Tomoko

AU - Asada, Yuki

AU - Akamine, Yukiko

AU - Sawai, Hashimu

AU - Kinosita, Masakazu

AU - Sudou, Tomomi

AU - Kunoki, Yoshiko

AU - Miki, Akiko

AU - Hori, Satoko

AU - Satoh, Hiroki

AU - Ohtani, Hisakazu

AU - Sawada, Yasufumi

PY - 2008/3

Y1 - 2008/3

N2 - The purpose of this study was to assess the bitterness intensity and pH of the solutions of clarithromycin dry syrup (CAM-DS), carbocisteine preparation (CC), and the concomitant use of both drugs. We conducted 6 types of human gustatory sensation tests with 6 healthy male volunteers. As a result, there was almost no difference in the bitterness intensity of CAM-DS between the branded (the latest and former preparations) and the generic formulations. The bitterness intensity of CAM-DS (the latest and former preparations of the branded as well as the generic formulations) was almost equally enhanced by mixing it with either the branded CC-DS or the branded and the generic carbocisteine granule (CC-Gr). On this occasion, the enhancing the bitterness of the branded CAM-DS (latest and former preparation) was nearly avoided safely by dosage form's changing CC-DS or CC-Gr to the branded CC-Sy. However, unlike the branded CC-Sy, some generic CC-Sy failed to suppress the bitterness. Furthermore, it was proven that some generic CAM-DS were shown to exhibit bitterness when mixed with even branded CC-Sy. In conclusion, it should be noted that the extent of bitterness of the mixture of CAM-DS and CC highly varies among the generic formulations.

AB - The purpose of this study was to assess the bitterness intensity and pH of the solutions of clarithromycin dry syrup (CAM-DS), carbocisteine preparation (CC), and the concomitant use of both drugs. We conducted 6 types of human gustatory sensation tests with 6 healthy male volunteers. As a result, there was almost no difference in the bitterness intensity of CAM-DS between the branded (the latest and former preparations) and the generic formulations. The bitterness intensity of CAM-DS (the latest and former preparations of the branded as well as the generic formulations) was almost equally enhanced by mixing it with either the branded CC-DS or the branded and the generic carbocisteine granule (CC-Gr). On this occasion, the enhancing the bitterness of the branded CAM-DS (latest and former preparation) was nearly avoided safely by dosage form's changing CC-DS or CC-Gr to the branded CC-Sy. However, unlike the branded CC-Sy, some generic CC-Sy failed to suppress the bitterness. Furthermore, it was proven that some generic CAM-DS were shown to exhibit bitterness when mixed with even branded CC-Sy. In conclusion, it should be noted that the extent of bitterness of the mixture of CAM-DS and CC highly varies among the generic formulations.

KW - Bitterness

KW - Branded formulation

KW - Carbocisteine

KW - Clarithromycin

KW - Generic formulation

UR - http://www.scopus.com/inward/record.url?scp=40449087952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449087952&partnerID=8YFLogxK

U2 - 10.1248/yakushi.128.479

DO - 10.1248/yakushi.128.479

M3 - Article

C2 - 18311069

AN - SCOPUS:40449087952

VL - 128

SP - 479

EP - 485

JO - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

JF - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

SN - 0031-6903

IS - 3

ER -